Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%
Ph phase_3
1
25%
Ph phase_4
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)

Trials by Status

completed375%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
unknownphase_3

Human Chorionic Gonadotrophin & Trigger

NCT02264847
completednot_applicable

A Study of Human Chorionic Gonadotrophin as Luteal Phase Support in Frozen Embryo Transfer

NCT01931384
completednot_applicable

Intrauterine Human Chorionic Gonadotrophins (hCG) and Endometrial Treg Cells

NCT01064219
completedphase_4

Intra-uterine Injection of Human Chorionic Gonadotrophin (hCG) Before Embryo Transfer

NCT01030393

Clinical Trials (4)

Showing 4 of 4 trials
NCT02264847Phase 3

Human Chorionic Gonadotrophin & Trigger

Unknown
NCT01931384Not Applicable

A Study of Human Chorionic Gonadotrophin as Luteal Phase Support in Frozen Embryo Transfer

Completed
NCT01064219Not Applicable

Intrauterine Human Chorionic Gonadotrophins (hCG) and Endometrial Treg Cells

Completed
NCT01030393Phase 4

Intra-uterine Injection of Human Chorionic Gonadotrophin (hCG) Before Embryo Transfer

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4